secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001104659-25-099196
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Northwest Biotherapeutics settles shareholder litigation over 2020 options; insurers to pay $2.25M
--------------------------------------------------------------------------------

- Settlement resolves Delaware Chancery litigation over 2020 option awards to management and directors.
- 17% of challenged options will be cancelled; company's insurers to pay $2.25 million to the company.
- Definitive settlement documentation due within 30 days; plaintiff's amended complaint covered by deal.
- Plaintiff intends to seek attorneys' fees and expenses, to be paid separately by insurers, subject to court approval.
- Cash payment from insurers cannot be used for fee award; both settlement and fee require court approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465925099196/0001104659-25-099196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465925099196/tm2528688d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-099196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer